Description
Gliclazide (GLIZ) MR 60/500mg Tablets (30’s)
Gliclazide MR 60/500mg is a modified-release combination tablet containing Gliclazide 60mg and Metformin Hydrochloride 500mg, formulated for the management of type 2 diabetes mellitus. This combination provides dual action to help maintain stable blood sugar levels.
Key Features:
-
Gliclazide MR (60mg): A sulfonylurea that stimulates insulin secretion with controlled release for a longer, steady effect.
-
Metformin (500mg): A biguanide that reduces hepatic glucose production and enhances insulin sensitivity.
-
Convenient extended-release formulation helps minimize gastrointestinal side effects.
-
Supports improved glycemic control when diet and exercise alone are insufficient.
-
Helps reduce blood sugar fluctuations with once or twice daily dosing.
Indications:
-
Treatment of type 2 diabetes mellitus in adults inadequately controlled by diet and exercise.
-
Suitable for patients requiring combination therapy of sulfonylurea and metformin.
Dosage & Administration:
-
Take with meals to reduce gastrointestinal discomfort.
-
Dose should be individualized based on clinical response and tolerance.
-
Regular blood sugar and kidney function monitoring is recommended.
Precautions:
-
Not recommended for type 1 diabetes or diabetic ketoacidosis.
-
Use with caution in renal or hepatic impairment.
-
Monitor for symptoms of hypoglycemia and lactic acidosis.
-
Inform healthcare professionals of all current medications.
Possible Side Effects:
-
Hypoglycemia (low blood sugar episodes)
-
Gastrointestinal issues such as nausea or diarrhea
-
Possible weight gain
-
Rare allergic reactions or lactic acidosis
Storage:
-
Store in a cool, dry place below 25°C.
-
Keep out of reach of children.
Reviews
There are no reviews yet.